On Tuesday, the Federal Circuit revived a life-sciences patent that was invalidated as being directed to a law of nature. The patent involved a method for multiple freeze-thaw cycles in liver cells. In Vitro Technologies designed the method by using previously frozen cells and then pooling the cells that remained viable for re-freezing and thawing […]
Continue Reading →On Tuesday, the Federal Circuit sustained an injunction preventing generic drug maker Apotex, Inc. from selling a similar version of Amgen Inc’s Neulasta drug without a 180 day notice period after being approved by the FDA. The drug is used to boost white blood cell counts in cancer patients and is made using living cells. […]
Continue Reading →The Federal Circuit has handed down its decision in Rapid Litigation Management v. CellzDirect. The technology at issue in the case is a method of freezing-and-thawing a group of hepatocytes and then selecting those that are still viable. The patent-owner sued the defendant for infringement of the patent, and the defendant in turn filed a […]
Continue Reading →The final judges scores are in, and the champions have been named for most utility patents received in 2015. IBM took home the gold medal with 7440 utility patents issued for the year. This software company, based in New York, has led the patent grant field for 23 consecutive years. The silver medal in 2015 went […]
Continue Reading →On June 27, the Supreme Court denied Sequenom’s petition from the Federal Circuit’s 2015 decision in Ariosa v. Sequenom. The relevant patent claimed methods of measuring cell-free fetal DNA (cffDNA) in maternal plasma and serum in order to identify fetal characteristics. The Federal Circuit assessed whether the claimed methods were directed to a naturally-occurring phenomenon, […]
Continue Reading →This is another test
Continue Reading →A test description
Continue Reading →This morning, the world woke to the news that the UK has voted to leave the European Union. While we will continue to see the far reaching consequences of this decision in the days to come, there are a few certainties concerning European intellectual property rights. The Effects Will Not be Immediate The Lisbon Treaty […]
Continue Reading →The Federal Circuit yesterday, in a ten-to-one decision, rejected Ethicon’s petition for en banc rehearing on the question of whether the USPTO Director improperly delegated decision-making authority for the institution of inter partes review (IPR) to a PTAB panel. This decision confirms another existing USPTO practice, the function of PTAB panels to both institute and […]
Continue Reading →The Supreme Court has issued its opinion in the case of In re Cuozzo Speed Technologies, LLC. In re Cuozzo initially began as an inter partes review (IPR) with the Patent Trial and Appeals Board (PTAB) where Garmin challenged the validity of Cuozzo’s patent relating to an interface that uses GPS technology to display a […]
Continue Reading →Receive the latest news and updates from us and our attorneys.
Sign Up